News Image

While growth is established for NASDAQ:HALO, the stock's valuation remains reasonable.

By Mill Chart

Last update: Nov 22, 2024

Our stock screening tool has pinpointed HALOZYME THERAPEUTICS INC (NASDAQ:HALO) as a growth stock that isn't overvalued. NASDAQ:HALO is excelling in various growth indicators while maintaining a solid financial footing. Furthermore, it remains attractively priced. Let's delve into the specifics below.


Affordable growth stocks image

Growth Assessment of NASDAQ:HALO

ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. NASDAQ:HALO scores a 9 out of 10:

  • The Earnings Per Share has grown by an impressive 55.33% over the past year.
  • HALO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 45.64% yearly.
  • Looking at the last year, HALO shows a very strong growth in Revenue. The Revenue has grown by 21.36%.
  • HALO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.42% yearly.
  • Based on estimates for the next years, HALO will show a very strong growth in Earnings Per Share. The EPS will grow by 25.47% on average per year.
  • HALO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.95% yearly.

Looking at the Valuation

ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NASDAQ:HALO has earned a 9 for valuation:

  • Compared to the rest of the industry, the Price/Earnings ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 97.68% of the companies listed in the same industry.
  • HALO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.96.
  • HALO is valuated reasonably with a Price/Forward Earnings ratio of 9.26.
  • HALO's Price/Forward Earnings ratio is rather cheap when compared to the industry. HALO is cheaper than 98.22% of the companies in the same industry.
  • HALO is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
  • 96.97% of the companies in the same industry are more expensive than HALO, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 97.15% of the companies listed in the same industry.
  • HALO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HALO has a very decent profitability rating, which may justify a higher PE ratio.
  • HALO's earnings are expected to grow with 32.04% in the coming years. This may justify a more expensive valuation.

Assessing Health for NASDAQ:HALO

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:HALO scores a 7 out of 10:

  • HALO has an Altman-Z score of 4.13. This indicates that HALO is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of HALO (4.13) is better than 78.25% of its industry peers.
  • HALO has a debt to FCF ratio of 3.83. This is a good value and a sign of high solvency as HALO would need 3.83 years to pay back of all of its debts.
  • HALO's Debt to FCF ratio of 3.83 is amongst the best of the industry. HALO outperforms 94.12% of its industry peers.
  • A Current Ratio of 10.36 indicates that HALO has no problem at all paying its short term obligations.
  • HALO has a better Current ratio (10.36) than 82.17% of its industry peers.
  • A Quick Ratio of 9.15 indicates that HALO has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 9.15, HALO is in the better half of the industry, outperforming 78.97% of the companies in the same industry.

Profitability Insights: NASDAQ:HALO

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:HALO, the assigned 7 is a significant indicator of profitability:

  • The Return On Assets of HALO (18.53%) is better than 98.40% of its industry peers.
  • HALO's Return On Equity of 86.69% is amongst the best of the industry. HALO outperforms 99.64% of its industry peers.
  • With an excellent Return On Invested Capital value of 19.23%, HALO belongs to the best of the industry, outperforming 97.68% of the companies in the same industry.
  • HALO had an Average Return On Invested Capital over the past 3 years of 17.78%. This is above the industry average of 15.31%.
  • The last Return On Invested Capital (19.23%) for HALO is above the 3 year average (17.78%), which is a sign of increasing profitability.
  • HALO has a Profit Margin of 41.43%. This is amongst the best in the industry. HALO outperforms 98.93% of its industry peers.
  • With an excellent Operating Margin value of 50.35%, HALO belongs to the best of the industry, outperforming 99.82% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 82.09%, HALO belongs to the top of the industry, outperforming 86.99% of the companies in the same industry.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

For an up to date full fundamental analysis you can check the fundamental report of HALO

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

HALOZYME THERAPEUTICS INC

NASDAQ:HALO (12/20/2024, 8:16:09 PM)

After market: 46.96 0 (0%)

46.96

-0.36 (-0.76%)

Follow us for more